{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:07:39Z","timestamp":1769922459570,"version":"3.49.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This study was designed to evaluate the effect of curcumin on H9c2 cardiac cell line and primary rat cardiac myocytes, using purified noradrenaline as a hypertrophy-inducing agent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The concentration of curcumin at which cells were treated was determined by MTT (3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. The effect of this safe dose in preventing noradrenaline-induced cardiac hypertrophy was assessed by biochemical analysis (estimating total protein content), molecular analysis (using RT-PCR to study the expression of fetal genes like ANF), immunological analysis (by determining the nuclear localization of GATA-4) and electrophoretic mobility shift assay (EMSA; to study DNA binding activity of GATA-4).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Curcumin at a concentration of 8 \u00b5m was found to suppress the increase in cell size, protein content and enhanced marker gene expression (ANF) caused by noradrenaline. Immunocytochemistry and Western blot analysis showed that curcumin suppressed the localization of transcription factor GATA-4 in the nucleus. It also showed a reduced DNA-binding activity in the presence of noradrenaline as confirmed by EMSA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These findings suggest that curcumin reduces the hypertrophic marker gene expression by inhibiting nuclear localization and DNA binding activity of GATA-4. Thus it has a great anti-hypertrophic potential.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.2042-7158.2011.01363.x","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T02:12:59Z","timestamp":1318558379000},"page":"1604-1612","source":"Crossref","is-referenced-by-count":33,"title":["Curcumin: a potential therapeutic polyphenol, prevents noradrenaline-induced hypertrophy in rat cardiac myocytes"],"prefix":"10.1093","volume":"63","author":[{"given":"Suchit","family":"Ahuja","sequence":"first","affiliation":[{"name":"Department of Biotechnology, Jaypee Institute of Information Technology , Noida, Uttar Pradesh,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrey","family":"Kohli","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Jaypee Institute of Information Technology , Noida, Uttar Pradesh,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Jaypee Institute of Information Technology , Noida, Uttar Pradesh,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Dogra","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Jaypee Institute of Information Technology , Noida, Uttar Pradesh,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Zoology, Government Post Graduate College , Noida, Uttar Pradesh,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibha","family":"Rani","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Jaypee Institute of Information Technology , Noida, Uttar Pradesh,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,12,1]]},"reference":[{"key":"2024103013291755700_cit1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.hfc.2009.12.001","article-title":"Hypertrophic cardiomyopathy","volume":"6","author":"Ho","year":"2010","journal-title":"Heart Fail Clin"},{"key":"2024103013291755700_cit2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"key":"2024103013291755700_cit3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/HJR.0b013e32833158a2","article-title":"Pathological and physiological hypertrophies are regulated by distinct gene programs","volume":"16","author":"Beisvag","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2024103013291755700_cit4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.physiol.63.1.391","article-title":"Cytoplasmic signaling pathways that regulate cardiac hypertrophy","volume":"63","author":"Molkentin","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"2024103013291755700_cit5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"2024103013291755700_cit6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","article-title":"Roles of cardiac transcription factors in cardiac hypertrophy","volume":"92","author":"Akazawa","year":"2003","journal-title":"Circ Res"},{"key":"2024103013291755700_cit7","first-page":"2758","article-title":"Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice","volume":"119","author":"Sundaresan","year":"2009","journal-title":"J Clin Invest"},{"key":"2024103013291755700_cit8","first-page":"611","article-title":"Signalling pathways in cardiac myocyte hypertrophy","volume":"33","author":"Sugden","year":"2001","journal-title":"Ann Med"},{"key":"2024103013291755700_cit9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/cvr\/cvp001","article-title":"Protein kinase C in heart failure: a therapeutic target?","volume":"82","author":"Palaniyandi","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"A","key":"2024103013291755700_cit10","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1253\/circj.CJ-08-0481","article-title":"Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure","volume":"72","author":"Oka","year":"2008","journal-title":"Circ J"},{"key":"2024103013291755700_cit11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/01.RES.84.6.633","article-title":"Signaling in myocardial hypertrophy: life after calcineurin?","volume":"84","author":"Sugden","year":"1999","journal-title":"Circ Res"},{"key":"2024103013291755700_cit12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cardiores.2004.03.025","article-title":"GATA transcription factors in the developing and adult heart","volume":"63","author":"Pikkarainen","year":"2004","journal-title":"Cardiovasc Res"},{"key":"2024103013291755700_cit13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.RES.0000218781.23144.3e","article-title":"Myocardin induces cardiomyocyte hypertrophy","volume":"98","author":"Xing","year":"2006","journal-title":"Circ Res"},{"key":"2024103013291755700_cit14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cardiores.2004.04.002","article-title":"Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes","volume":"63","author":"Fiedler","year":"2004","journal-title":"Cardiovasc Res"},{"key":"2024103013291755700_cit15","first-page":"4","article-title":"NF-\u03baB: a novel therapeutic target for cancer","volume":"1","author":"Paul","year":"2005","journal-title":"Eukaryon"},{"key":"2024103013291755700_cit16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-0-387-46401-5_21","article-title":"Clinical studies with curcumin","volume":"595","author":"Hsu","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"2024103013291755700_cit17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2006-960004","article-title":"Pharmacology of Curcuma longa","volume":"57","author":"Ammon","year":"1991","journal-title":"Planta Med"},{"key":"2024103013291755700_cit18","first-page":"850","article-title":"Currying favor for the heart","volume":"118","author":"Epstein","year":"2008","journal-title":"J Clin Invest"},{"key":"2024103013291755700_cit19","first-page":"868","article-title":"The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats","volume":"118","author":"Morimoto","year":"2008","journal-title":"J Clin Invest"},{"key":"2024103013291755700_cit20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1253\/circj.CJ-09-1012","article-title":"Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin","volume":"74","author":"Morimoto","year":"2010","journal-title":"Circ J"},{"key":"2024103013291755700_cit21","doi-asserted-by":"crossref","first-page":"E1119","DOI":"10.1152\/ajpendo.00029.2008","article-title":"Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level","volume":"294","author":"Feng","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024103013291755700_cit22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1172\/JCI111023","article-title":"Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response","volume":"72","author":"Simpson","year":"1983","journal-title":"J Clin Invest"},{"key":"2024103013291755700_cit23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11626-007-9079-4","article-title":"An improved protocol for primary culture of cardiomyocyte from neonatal mice","volume":"44","author":"Sreejit","year":"2008","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2024103013291755700_cit24","first-page":"4435","article-title":"Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay","volume":"49","author":"Plumb","year":"1989","journal-title":"Cancer Res"},{"key":"2024103013291755700_cit25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"2024103013291755700_cit26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bbrc.2004.08.157","article-title":"Isolation of a library of target-sites for sequence specific DNA binding proteins from chick embryonic heart: a potential tool for identifying novel transcriptional regulators involved in embryonic development","volume":"323","author":"Sindhu","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2024103013291755700_cit27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/ecam\/nem042","article-title":"Inhibitory effects of Bangladeshi medicinal plant extracts on interactions between transcription factors and target DNA sequences","volume":"5","author":"Lampronti","year":"2008","journal-title":"Evid Based Complement Alternat Med"},{"key":"2024103013291755700_cit28","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: from ancient medicine to current clinical trials","volume":"65","author":"Hatcher","year":"2008","journal-title":"Cell Mol Life Sci"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7158.2011.01363.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/63\/12\/1604\/60235302\/j.2042-7158.2011.01363.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/63\/12\/1604\/60235302\/j.2042-7158.2011.01363.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:55:22Z","timestamp":1730314522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/63\/12\/1604\/6135447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,1]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,1]]},"published-print":{"date-parts":[[2011,12,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7158.2011.01363.x","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,12]]},"published":{"date-parts":[[2011,12,1]]}}}